Moderna Inc (MRNA)

Financial leverage ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total assets	US$ in thousands	18,426,000	25,858,000	24,669,000	7,337,000	1,589,420
Total stockholders’ equity	US$ in thousands	13,854,000	19,123,000	14,145,000	2,561,000	1,175,000
Financial leverage ratio		1.33	1.35	1.74	2.86	1.35

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $18,426,000K ÷ $13,854,000K
= 1.33

The financial leverage ratio of Moderna Inc has shown fluctuation over the past five years. In 2019, the ratio was 1.35, indicating that the company had a moderate level of financial leverage. However, by the end of 2020, the ratio increased significantly to 2.86, suggesting a substantial increase in financial leverage, which may indicate higher financial risk.

In the following years, the financial leverage ratio decreased, reaching 1.33 at the end of 2023. This downward trend in the ratio indicates a reduction in the company's reliance on debt financing compared to its equity, which could be seen as a positive sign of improved financial stability and lower risk.

Overall, the trend in Moderna Inc's financial leverage ratio shows fluctuation with a notable increase in 2020 followed by a subsequent decrease in the following years. Monitoring this ratio over time can provide insights into the company's financial strategy and risk management practices.